{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:49Z","timestamp":1790651989697,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jns.2024.123215","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T06:24:31Z","timestamp":1725431071000},"page":"123215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"466","author":[{"given":"Hye Lim","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Myoung","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Young","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seol-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Youl","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Young","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeol-A","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Hee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Yang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2024.123215_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000448286","article-title":"Multiple autoantibodies and Neuromyelitis Optica Spectrum disorders","volume":"23","author":"Chen","year":"2016","journal-title":"Neuroimmunomodulation"},{"issue":"11","key":"10.1016\/j.jns.2024.123215_bb0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10067-010-1502-7","article-title":"Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature","volume":"29","author":"Sergio","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.jns.2024.123215_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-014-3066-3","article-title":"Neuromyelitis optica spectrum disorders associated with other autoimmune diseases","volume":"35","author":"Freitas","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.jns.2024.123215_bb0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/acr.23107","article-title":"Relationship between Neuromyelitis Optica Spectrum disorder and Sj\u00f6gren\u2019s syndrome: central nervous system Extraglandular disease or unrelated, co-occurring autoimmunity?","volume":"69","author":"Birnbaum","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.jns.2024.123215_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ene.12714","article-title":"Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica","volume":"23","author":"Masuda","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2024.123215_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/neu.2016.49","article-title":"Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica","volume":"29","author":"Pereira","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jns.2024.123215_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2016.11.010","article-title":"The clinical characteristics of AQP4 antibody positive NMO\/SD in a large cohort of Chinese Han patients","volume":"302","author":"ZhangBao","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jns.2024.123215_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non\u2013organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2024.123215_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2016.04.039","article-title":"Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders","volume":"366","author":"Wang","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2024.123215_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1352458520933884","article-title":"Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD","volume":"27","author":"Kunchok","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2024.123215_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103494","article-title":"Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders","volume":"58","author":"Lin","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123215_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"Park","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123215_bb0065","series-title":"Establishment and Management of Neuromyelitis optica (NMO) and NMO Spectrum Disorders (NMOSD) Nationwide Multicenter Registry in Korea","author":"Lee","year":"2018"},{"issue":"4","key":"10.1016\/j.jns.2024.123215_bb0070","first-page":"685","article-title":"Evaluation of immunoturbidimetric rheumatoid factor method from Diagam on Abbott c8000 analyzer: comparison with immunonephelemetric method","volume":"60","author":"Dupuy","year":"2014","journal-title":"Clin. Lab."},{"issue":"11","key":"10.1016\/j.jns.2024.123215_bb0075","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jns.2024.123215_bb0080","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1007\/s00415-014-7506-5","article-title":"Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"261","author":"Koudriavtseva","year":"2014","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2024.123215_bb0085","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1007\/s00415-013-7128-3","article-title":"Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder","volume":"260","author":"Long","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123215_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2016.09.039","article-title":"Low T3 syndrome in neuromyelitis optica spectrum disorder: associations with disease activity and disability","volume":"370","author":"Cho","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2024.123215_bb0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acn3.51053","article-title":"Immune-mediated axonal dysfunction in seropositive and seronegative primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Tani","year":"2020","journal-title":"Ann. Clin. Translat. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2024.123215_bb0100","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458513515085","article-title":"Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset","volume":"20","author":"Collongues","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"13","key":"10.1016\/j.jns.2024.123215_bb0105","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1177\/1352458516685416","article-title":"Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: a multicenter retrospective study in Korea","volume":"23","author":"Seok","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"12","key":"10.1016\/j.jns.2024.123215_bb0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jns.2024.123215_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/eji.1830270323","article-title":"Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage","volume":"27","author":"B\u00f8rretzen","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jns.2024.123215_bb0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sjogren\u2019s Syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.jns.2024.123215_bb0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10875-011-9553-3","article-title":"Active immunological profile is associated with systemic Sjogren\u2019s syndrome","volume":"31","author":"Martel","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jns.2024.123215_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000442203","article-title":"Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis","volume":"46","author":"Tettey","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"26","key":"10.1016\/j.jns.2024.123215_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003999","article-title":"Increased incidence of rheumatoid arthritis in multiple sclerosis: a nationwide cohort study","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.jns.2024.123215_bb0140","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2024.123215_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000104","article-title":"B lymphocytes in neuromyelitis optica","volume":"2","author":"Bennett","year":"2015","journal-title":"Neurol.-Neuroimmunol. Neuroinflammat."},{"issue":"14","key":"10.1016\/j.jns.2024.123215_bb0150","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.95.14.8222","article-title":"Interleukin 6 plays a key role in the development of antigen-induced arthritis","volume":"95","author":"Ohshima","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jns.2024.123215_bb0155","first-page":"363","article-title":"Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis","volume":"9","author":"Sawada","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.jns.2024.123215_bb0160","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol.-Neuroimmunol. Neuroinflammat."},{"issue":"4","key":"10.1016\/j.jns.2024.123215_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000494976","article-title":"Cytokines and tissue damage biomarkers in first-onset neuromyelitis optica spectrum disorders: significance of interleukin-6","volume":"25","author":"Wei","year":"2019","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jns.2024.123215_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fncel.2020.00120","article-title":"IL-6 in the cerebrospinal fluid signals disease activity in multiple sclerosis","volume":"14","author":"Stampanoni Bassi","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2024.123215_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(81)90063-0","article-title":"IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients","volume":"51","author":"Ziola","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123215_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S1676-24442013000100002","article-title":"Comparative study between immunoturbidimetric and latex agglutination methods for the detection of rheumatoid factor","volume":"49","author":"Rocha","year":"2013","journal-title":"J. Brasil. de Patol. e Med. Laborator."},{"key":"10.1016\/j.jns.2024.123215_bb0185","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-019-04438-z","article-title":"Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients","volume":"38","author":"Ma\u015bli\u0144ska","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jns.2024.123215_bb0190","series-title":"Anticardiolipin Testing, Hughes Syndrome: Antiphospholipid Syndrome","first-page":"275","author":"Pierangeli","year":"2000"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:05:30Z","timestamp":1741064730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":38,"alternative-id":["S0022510X24003502"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123215","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123215"}}